Clader JW - Search Results

1

Substituted 2-azaspiro[5.3]nonan-1-ones as potent cholesterol absorption inhibitors: defining a binding conformation for SCH 48461.

Dugar S, Clader JW, Chan TM, Davis H Jr. Dugar S, et al. Among authors: clader jw. J Med Chem. 1995 Dec 8;38(25):4875-7. doi: 10.1021/jm00025a002. J Med Chem. 1995. PMID: 8523398 No abstract available.

2

Synthesis of iodinated biochemical tools related to the 2-azetidinone class of cholesterol absorption inhibitors.

Burnett DA, Caplen MA, Domalski MS, Browne ME, Davis HR Jr, Clader JW. Burnett DA, et al. Among authors: clader jw. Bioorg Med Chem Lett. 2002 Feb 11;12(3):311-4. doi: 10.1016/s0960-894x(01)00750-8. Bioorg Med Chem Lett. 2002. PMID: 11814785

3

Synthesis of fluorescent biochemical tools related to the 2-azetidinone class of cholesterol absorption inhibitors.

Burnett DA, Caplen MA, Browne ME, Zhau H, Altmann SW, Davis HR, Clader JW. Burnett DA, et al. Among authors: clader jw. Bioorg Med Chem Lett. 2002 Feb 11;12(3):315-8. doi: 10.1016/s0960-894x(01)00752-1. Bioorg Med Chem Lett. 2002. PMID: 11814786

4

Inhibitors of acyl CoA:cholesterol acyltransferase.

Vaccaro W, Amore C, Berger J, Burrier R, Clader J, Davis H, Domalski M, Fevig T, Salisbury B, Sher R. Vaccaro W, et al. J Med Chem. 1996 Apr 12;39(8):1704-19. doi: 10.1021/jm950833d. J Med Chem. 1996. PMID: 8648610

5

Substituted (1,2-diarylethyl)amide acyl-CoA:cholesterol acyltransferase inhibitors: effect of polar groups on in vitro and in vivo activity.

Clader JW, Berger JG, Burrier RE, Davis HR, Domalski M, Dugar S, Kogan TP, Salisbury B, Vaccaro W. Clader JW, et al. J Med Chem. 1995 May 12;38(10):1600-7. doi: 10.1021/jm00010a004. J Med Chem. 1995. PMID: 7752185

6

2-Azetidinones as inhibitors of cholesterol absorption.

Burnett DA, Caplen MA, Davis HR Jr, Burrier RE, Clader JW. Burnett DA, et al. Among authors: clader jw. J Med Chem. 1994 Jun 10;37(12):1733-6. doi: 10.1021/jm00038a001. J Med Chem. 1994. PMID: 8021912 No abstract available.

7

2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus.

Clader JW, Burnett DA, Caplen MA, Domalski MS, Dugar S, Vaccaro W, Sher R, Browne ME, Zhao H, Burrier RE, Salisbury B, Davis HR Jr. Clader JW, et al. J Med Chem. 1996 Sep 13;39(19):3684-93. doi: 10.1021/jm960405n. J Med Chem. 1996. PMID: 8809157

8

Synthesis of C3 heteroatom-substituted azetidinones that display potent cholesterol absorption inhibitory activity.

McKittrick BA, Ma K, Huie K, Yumibe N, Davis H Jr, Clader JW, Czarniecki M, McPhail AT. McKittrick BA, et al. Among authors: clader jw. J Med Chem. 1998 Feb 26;41(5):752-9. doi: 10.1021/jm970676d. J Med Chem. 1998. PMID: 9513603

9

Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4 -hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption.

Rosenblum SB, Huynh T, Afonso A, Davis HR Jr, Yumibe N, Clader JW, Burnett DA. Rosenblum SB, et al. Among authors: clader jw. J Med Chem. 1998 Mar 12;41(6):973-80. doi: 10.1021/jm970701f. J Med Chem. 1998. PMID: 9526571

10

Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.

Billard W, Binch H, Bratzler K, Chen LY, Crosby G Jr, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW. Billard W, et al. Among authors: clader jw. Bioorg Med Chem Lett. 2000 Oct 2;10(19):2209-12. doi: 10.1016/s0960-894x(00)00437-6. Bioorg Med Chem Lett. 2000. PMID: 11012031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters